🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: \- to investigate the effect of food on the bioavailabi...
Status
Completed
Location
CROSS Research S.A., I Unit
Start Date
2020-10-20
Trial ID
NCT04854642
Treatments Being Tested
This is a phase I/II, open-label, study of twice-daily oral ladarixin with ...
Status
Recruiting
Location
NYU Langone Health
Start Date
2023-08-01
Trial ID
NCT05815173
Objectives Primary study objective: To determine whether orally-administere...
Status
Withdrawn
Location
Institute of Cellular Therapeutics Allegheny Health Network
Start Date
2021-09-30
Trial ID
NCT05035368
Primary objective \- To determine whether oral ladarixin versus placebo ad...
Status
Terminated
Location
Ospedale F. Spaziani Frosinone
Start Date
2022-09-14
Trial ID
NCT05368402
The objective of this clinical trial is to investigate whether ladarixin ha...
Status
Completed
Location
Universitair Ziekenhuis Brussel Diabetes Clinic
Start Date
2016-08
Trial ID
NCT02814838
Study record has been combined with NCT05815173. See NCT05815173 for summar...
Status
Withdrawn
Location
NYU Langone Health
Start Date
2024-04
Trial ID
NCT05815186
The objective of this clinical trial was to assess whether ladarixin treatm...
Status
Terminated
Location
University of Colorado School of Medicine - Barbara Davis Center for Childhood Diabetes (BDC) - Specialty Clinic
Start Date
2020-12-14
Trial ID
NCT04899271
Objectives The objective of this clinical trial is to assess whether ladari...
Status
Terminated
Location
University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Multidisciplinary Comprehensive Diabetes Clinic (MCDC)
Start Date
2021-01-12
Trial ID
NCT04628481